Chinese Journal of Contemporary Neurology and Neurosurgery ›› 2020, Vol. 20 ›› Issue (1): 15-21. doi: 10.3969/j.issn.1672-6731.2020.01.004

Previous Articles     Next Articles

Progress in the regulation of B cells in atherosclerotic stroke

ZOU Yu-tian, ZHANG Yan-lin, CAO Yong-jun   

  1. Department of Neurology, Second Affiliated Hospital of Soochow University, Suzhou 215004, Jiangsu, China
  • Received:2019-12-16 Online:2020-01-25 Published:2020-01-21
  • Supported by:

    This study was supported by the National Natural Science Foundation of Young Scientist of China (No. 81701149) and the Science and Technology Project of Health and Planning Commission in Suzhou of Jiangsu Province in 2018 (No. LCZX201806).

B细胞调控动脉粥样硬化性卒中研究进展

邹钰钿, 张艳林, 曹勇军   

  1. 215004 苏州大学附属第二医院神经内科
  • 通讯作者: 曹勇军,Email:yongjuncao@126.com;张艳林,Email:zhangyanlin0012006@163.com
  • 基金资助:

    国家自然科学基金青年科学基金资助项目(项目编号:81701149);2018年度江苏省苏州市卫生计生委科技项目(项目编号:LCZX201806)

Abstract:

Atherosclerosis is one of the main pathological basis of ischemic stroke. Recent studies have found that arterial tertiary lymphoid organs (ATLOs) is rich in B lymphocytes, which play an important regulatory role in the formation and progress of atherosclerosis plaque through local immune response. Some B-cell regulatory factors can also reduce the volume of ischemic stroke cerebral infarction, which is expected to be a new treatment option for ischemic stroke. This paper aims to review the role and mechanism of B lymphocyte subsets in regulating the progress of atherosclerosis and ischemic stroke. It will be helpful to explore the immune mechanism and immunotherapeutic potential of the occurrence and progress of atherosclerosis and ischemic stroke.

Key words: Stroke, Atherosclerosis, B-lymphocytes, Immunotherapy, Review

摘要:

动脉粥样硬化是缺血性卒中的主要病理学基础。近年研究发现,动脉第三淋巴器官富含B细胞,可通过局部免疫应答对动脉粥样硬化斑块的形成与进展发挥重要调节作用;其中部分B细胞调控因子可使梗死灶体积缩小,有望成为缺血性卒中治疗的替代性选择。本文拟对B细胞亚群参与调控动脉粥样硬化和缺血性卒中进展的作用与机制进行综述,以助于探寻动脉粥样硬化、缺血性卒中发生发展的免疫机制及免疫治疗潜能。

关键词: 卒中, 动脉粥样硬化, B-淋巴细胞, 免疫疗法, 综述